| 1 |
石少敏, 赵建军, 于杜鹃, 等. miR-320a靶向Rab11a调控非小细胞肺癌细胞增殖的研究 [J]. 中国实验诊断学, 2018, 22(9): 1636-1638.
|
| 2 |
Sanchez Calle A, Kawamura Y, Yamamoto Y, et al. Emerging roles of long non-coding RNA in cancer [J]. Cancer Sci, 2018, 109(7): 2093-2100.
|
| 3 |
Zhou W, Chen X, Hu Q, et al. Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression [J]. BMC Cancer, 2018, 18(1): 580.
|
| 4 |
Liu L, Liu L, Lu S. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3 [J]. Int J Oncol, 2019, 54(3): 929-941.
|
| 5 |
Luo J, Wang K, Yeh S, et al. LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling [J]. Nat Commun, 2019, 10(1): 2571.
|
| 6 |
Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention [J]. Clin Chest Med, 2011, 32(4): 605-644.
|
| 7 |
Ghafouri-Fard S, Shirvani-Farsani Z, Hussen BM, et al. The critical roles of lncRNAs in the development of osteosarcoma [J]. Biomed Pharmacother, 2021, 135: 111217.
|
| 8 |
Tang Q, Hann SS. HOTAIR: An oncogenic long non-coding RNA in human cancer [J]. Cell Physiol Biochem, 2018, 47(3): 893-913.
|
| 9 |
Collette J, Le Bourhis X, Adriaenssens E. Regulation of human breast cancer by the long non-coding RNA H19 [J]. Int J Mol Sci, 2017, 18(11): 2319.
|
| 10 |
Jia Y, Duan Y, Liu T, et al. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5 [J]. Cell Death Dis, 2019, 10(8): 573.
|
| 11 |
Zhao M, Xin XF, Zhang JY, et al. LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling [J]. Cancer Med, 2020, 9(3): 1196-1208.
|
| 12 |
Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development [J]. Nat Rev Genet, 2014,15(1): 7-21.
|
| 13 |
Yang F, Zhang H, Mei Y, et al. Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect [J]. Mol Cell, 2014, 53(1): 88-100.
|
| 14 |
Dimitrova N, Zamudio JR, Jong RM, et al. LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint [J]. Mol Cell, 2014, 54(5): 777-790.
|
| 15 |
Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response [J]. Cell, 2010, 142(3): 409-419.
|
| 16 |
Wang X, Ruan Y, Wang X, et al. Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer [J]. Cell Prolif, 2017, 50(2): e12318.
|
| 17 |
Işın M, Uysaler E, Özgür E, et al. Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease [J]. Front Genet, 2015, 6: 168.
|
| 18 |
Yan MD, Lin HY, Hwang PA. The anti-tumor activity of brown seaweed oligo-fucoidan via lncRNA expression modulation in HepG2 cells [J]. Cytotechnology, 2019, 71(1): 363-374.
|
| 19 |
裴洪利, 白尚星. 过表达lncRNA-p21通过介导Wnt/β-catenin信号通路抑制胃癌MGC-803细胞的生长与转移 [J]. 临床与病理杂志, 2019, 39(8): 1615-1621.
|
| 20 |
Ding J, Xie M, Lian Y, et al. Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer [J]. Oncogenesis, 2017, 6(1): e288.
|
| 21 |
汪小霞, 孟刚, 李丽, 等. 乳腺癌中EZH2和p53蛋白表达及其临床意义 [J]. 临床与实验病理学杂志, 2015, 31(3): 273-276.
|
| 22 |
Jiang B, Chen J, Yuan W, et al. Platelet-derived growth factor-D promotes colorectal cancer cell migration, invasion and proliferation by regulating notch1 and matrix metalloproteinase 9 [J]. Oncol Lett, 2018, 15(2): 1573-1579.
|
| 23 |
张冠磊, 马苗苗, 兰文静, 等. LncRNA-p21调控Notch信号通路对非小细胞肺癌A549细胞增殖、迁移及侵袭的影响 [J]. 肿瘤防治研究, 2021, 48(2): 121-126.
|
| 24 |
张卫强, 赵京, 刘克强, 等. miR-25-3p和PHLPP2在肺腺癌中的表达及其与预后的相关性分析 [J]. 重庆医学, 2020, 49(23): 3936-3940.
|